Berenberg Bank Reiterates Buy Rating for Advanced Medical Solutions Group (LON:AMS)

Key Points

• Berenberg Bank has reiterated a "buy" rating for Advanced Medical Solutions Group (AMS) with a price target of GBX 300, indicating a potential upside of 40.19% from its previous close.
• Deutsche Bank also reaffirmed a "buy" rating with a lower price target of GBX 275, contributing to a consensus rating of "Buy" with an average price target of GBX 287.50.
• AMS specializes in innovative tissue-healing technology and has a diverse portfolio of surgical products, showing robust financial metrics such as a current ratio of 8.39 and a market capitalization of £462.52 million.

Advanced Medical Solutions Group (LON:AMS - Get Free Report)'s stock had its "buy" rating restated by research analysts at Berenberg Bank in a report issued on Wednesday, MarketBeat.com reports. They presently have a GBX 300 target price on the stock. Berenberg Bank's price objective would indicate a potential upside of 41.18% from the company's previous close.

Separately, Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a GBX 275 price objective on shares of Advanced Medical Solutions Group in a research note on Wednesday, July 16th. Three investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock has a consensus rating of "Buy" and an average target price of GBX 273.67.

Advanced Medical Solutions Group Price Performance

Shares of AMS stock traded up GBX 1.50 on Wednesday, reaching GBX 212.50. 525,182 shares of the company were exchanged, compared to its average volume of 810,801. The company has a market cap of £459.28 million, a price-to-earnings ratio of 6,538.46, a P/E/G ratio of 5.00 and a beta of 0.74. The business has a 50-day moving average price of GBX 205.22 and a 200 day moving average price of GBX 203.18. The company has a debt-to-equity ratio of 37.01, a quick ratio of 4.58 and a current ratio of 8.39. Advanced Medical Solutions Group has a 1 year low of GBX 168.40 and a 1 year high of GBX 243.

Advanced Medical Solutions Group (LON:AMS - Get Free Report) last released its earnings results on Wednesday, September 17th. The company reported GBX 5.77 EPS for the quarter. Advanced Medical Solutions Group had a net margin of 8.49% and a return on equity of 4.57%. Equities research analysts forecast that Advanced Medical Solutions Group will post 9.8159509 earnings per share for the current fiscal year.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.